HPC Elects to Conduct Cost and Market Impact Review of Proposed New CVS and Mass General Brigham Primary Care Partnership
HPC will review potential implications on primary care access, quality, and cost
Press Release
Massachusetts Hospitals Rapidly Scale Up Hospital at Home Model
Patient use increased tenfold from 2020 to 2024; Medicare’s participation set to expire September 30, 2025, absent immediate Congressional action
Statement from HPC Executive Director David Seltz on New HPC Board
“The Massachusetts Health Policy Commission (HPC) extends our sincere gratitude to Governor Maura Healey for the reappointment of HPC Board Chair Deborah Devaux and appointment of new and returning members to the HPC Board of Commissioners. The full slate of commissioners bring essential experience and policy expertise to the Board, and their leadership will help guide the HPC in addressing some of the Commonwealth’s most pressing challenges – including mounting affordability issues, workforce constraints, and threats to health care access."
HPC Shares New Research on Improving Affordability and Predictability in Cost Sharing, Announces the Launch of New Pharmaceutical and Health Planning Offices
Commissioners also voted to initiate the first retrospective cost and market impact review of Beth Israel Lahey Health’s 2019 formation
HPC Sets 2026 Health Care Benchmark at 3.6% and Calls for Renewed Commitment to Affordability Across Health Care System
HPC issues final report on cost and market impact review of new Dana-Farber-Beth Israel cancer care collaboration
Primary Care Task Force Launched To Stabilize and Strengthen Massachusetts Primary Care
New effort co-chaired by HPC and EOHHS tasked with recommending a new primary care spending target, improving patient access, and strengthening workforce
Massachusetts Launches Effort To Improve Maternal Health Access, Quality, and Safety
New task force co-chaired by the Health Policy Commission and Department of Public Health begins critical work to assess and provide policy recommendations for maternal health care in Massachusetts
Health Care Spending Grew Faster Than Inflation, Labor Costs, and Income, Exacerbating Affordability Challenges for Massachusetts Residents
A major driver of spending growth is pharmaceutical spending, which, net of rebates, increased by $1 billion or 10% from 2022 to 2023
BOSTON — The Massachusetts Health Policy Commission (HPC), in conjunction with the Legislature’s Joint Committee on Health Care Financing, held the Health Care Cost Growth Benchmark Hearing today, an annual hearing to assess performance against last year’s benchmark and consider the target for the next year (calendar year 2026).
Health Policy Commission Executive Director David Seltz: Statement on CHIA’s Annual Report
BOSTON — “CHIA’s Annual Report on the Performance of the Massachusetts Health Care System documents that health care cost growth is continuing to grow at an alarming pace. Total health care expenditures totaled $78.1 billion dollars in 2023, representing 8.6% growth from the prior year -- far surpassing the state’s health care cost growth benchmark of 3.6%, with real ramifications for our residents and businesses.
Health Policy Commission Issues Preliminary Report for 10th Cost and Market Impact Review: New Dana Farber-Beth Israel Partnership
Proposed affiliation and new cancer hospital would be a significant realignment for cancer care among major Massachusetts health care providers